Floatz logo

Metformin

Type 1 Diabetes

Heba M. IsmailSmall moleculePhase 4 / ApprovedActive
A
80/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
70/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Type 1 Diabetes cohort.

Asset / SponsorPhaseRating
Liraglutide
Dasman Diabetes Institute
Phase 4BBB
Tirzepatide
Royal North Shore Hospital
Phase 4BBB
Semaglutide
Nordsjaellands Hospital
Phase 3BB
ct-868
Carmot Therapeutics, Inc.
Phase 2BB
Miglitol
Phase 3BB

View all 23 →

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →